50 / 144
330
of late-onset dementia in a multicentre, community-
based population in England and Wales. Neuropathology
Group of the Medical Research Council Cognitive Function
and Ageing Study (MRC CFAS). Lancet, 2001 357 (9251):
169–175.
13. Hecaen H. Introduction a la neuropsychologie. Paris.
Larousse.1972.
14. Therapeutics and Technology Assessment Subcommittee
of the American Academy of Neurology. Assessment
Neuropsychological testing of adults. Neurology,1996; 47:
592-599.
15. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ Grant
E, et al. (2005). The AD8: A brief informant interview to
detect dementia. Neurology 2005; 65: 559-64.
16. Jorm AF, Jacomb PA. The Informant Questionnaire
on Cognitive Decline in the Elderly (IQCODE): Socio-
demographic correlates, reliability, validity and some
norms. Psychol Med 1989;19:1015-22.
17. Blessed G, Tomlinson BE, Roth M. The association between
quantitative measures of dementia and of senile change in
the cerebral grey matter of elderly subjects. Br J, Psychiatry
1968; 114:797-811.
18. Folstein MF, Folstein SE, Mchugh PR. “Mini-mental state”. A
practical method for grading the cognitive state of patients
for the clinician. J Psychiatr Res 1975; 12: 189-98.
19. Mosselli E, Bonsinelli M. Mini-Mental State Examination: a
30 year story 2006; Aging Clin Exp Res. 2006;18(4):271-3.
20. Carnero-Pardo C. ¿Es hora de jubilar al Mini-Mental?.
Neurología 2014; 29:473-81
21. Mattis, S. Mental status examination for organic mental
syndrome in the elderly patient. In. L. Bellak & T.B.
Karasu (Eds.), Geriatric psychiatry. Grune & Stratton.New
York.1976.
22. Rosen WG, Mohs RC, Davids KL. A new rating scale for
Alzheimer´s disease. Am J Psychiatry 1984;141, 1356-
1364.
23. Huppert FA, Brayne C, Gill et al. CAMCOG a concise
neuropsychological test to assist dementia diagnosis:
Socio-demographic determinants is an elderly population
simple. Br J Clin Psychol 1995; 34, 529-541.
24. Reisberg B, Borenstein J, Franssen E et al. BEHAVE-AD: A
clinical rating scale for the assessment of pharmacologically
remediable behavioral symptomatology in Alzheimer´s
disease. In Altam (Ed.) Alzheimer´s diseasae. Plenum. New
York.1987.
25. Cumming JL, Mega M, Gray K et al. The Neuropsychiatric
Inventory: comprensive assessment of psychopathology in
dementia. Neurology 1994; 44, 2308-2314.
26. Reisberg B, Ferris S, de Leon MJ et al. Stage-specific
behavioral, cognitive, and in vivo changes in community
residing subjects with age associated memory impairment
and primary degenerative dementia of the Alzheimer type.
Drug DevRes 1988; 15: 101–14.
27. Petersen RC, Smith GE, Waring SC, Ivanik RJ, Tangelos E, Kokmen
E. Mild cognitive impairment: clinical characterization and
outcome. Arch Neurol 1999; 56 (3): 303-8.
28. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F,
Scheltens Ph et al. Mild cognitive impairment (MCI) in
medical practice: a critical review of the concept and new
diagnostic procedure. Report of the MCI Working Group of
the European Consortium on Alzheimer’s Disease 2006; J
Neurol Neurosurg Psychiatry 2006;77, 714–718.
29. Albert, MS, DeKosky ST, Dickson D, Dubois B, Feldman HH,
Fox N. et al. The diagnosis of mild cognitive impairment
due to Alzheimer’s disease: Recommendations from the
National Institute on Aging-Alzheimer’s Association
workgroups on diagnostic guidelines for Alzheimer’s
disease. Alzheimers Dement 2011; 7, 270-279.
30. Diagnostic and Statistical Manual of Mental Disorders, fifth
edition (DSM- 5). Washington, DC: American Psychiatric
Association, 2013.
31. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild
cognitive impairment. Arch Neurol. 2001; 58:1985–1992.
32. Mckhann G, Drachman D, Folstein M, Katzman R, Price
D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease:
Report of the NINCDS-ADRDA Work Group under the
auspices of Department of Health and Human Services
Task Force on Alzheimer’s Disease. Neurology 1984; 34:
939-44.
33. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges
JR. A brief cognitive test battery to differentiate Alzheimer’s
disease and frontotemporal dementia. Neurology 2000;
55: 1613-20.
34. Grober, E., & Buschke, H. Genuine memory deficits in
dementia. Dev Neuropsychol 1987; 3, 13-36.
35. Delis DC, Kaplan, E, Kramer JH, Ober BA. California
Verbal Learning Test. San Antonio, TX: The Psychological
Corporation 1987.
36. Ergis A, E. Eusop-Roussel. Les troubles précoces de la
mémoire épisodique dans la maladie d’Alzheimer. Revue
Neurologique 2009: S96-S101.
37. Souchay C. Metamemory in Alzheimer´s Disease. Cortex
2007; 43:987-1003.
38. Belleville S. La maladie d’Alzheimer : une maladie de la
mémoire de travail ? , Revue de neuropsychologie 2009;1,
51-58.
39. Kullman DM. Attention and executive deficits in Alzheimer’s
disease A critical review. Brain 1999; 383-404.
40. Liketsos CG, CarilloMC, Ryan JM, Khachaturian AS,
Trzepacz P, Amatniek J et al. Neuropsychiatric symptoms
in Alzheimer´s disease. Alzheimer dement 2011;7,5,
532-539.
41. Tomlinson BE, Blessed G, Roth M. Observations on the
brains of demented old people. J Neurol Sci 1970; 11:
205-242.
42. World Health Organization. Classification of diseases. 10 ed.
The ICD-10 classification of mental and behavioural disorders:
clinical descriptors and diagnostic guidelines. Geneva. 1992.
[REV. MED. CLIN. CONDES - 2016; 27(3) 319-331]